Viking Therapeutics stock sinks after mixed results from its obesity pill trial, raising doubts over safety, tolerability and ...

This week on "The Readout LOUD," we discuss Viking Therapeutics' obesity flop and dish on the growing "pharm to table" movement.

The most profitable trades in history often begin in moments of panic. And few moments felt more hopeless than the fall of ...

(Reuters) -Telehealth company Ro has tapped tennis star Serena Williams as a celebrity patient ambassador for its weight-loss ...

Telehealth company Ro has tapped tennis star Serena Williams as a celebrity patient ambassador for its weight-loss treatments, the company said Thursday. Read more at straitstimes.com. Read more at ...

No one stays on top forever. It’s a lesson that Ozempic maker Novo Nordisk may be painfully learning about. The Danish ...

Telehealth company Ro has enlisted former tennis player Serena Williams as a celebrity patient ambassador for its weight-loss treatments, it said on Thursday. Read more at straitstimes.com. Read more ...

With promising new obesity treatments in the pipeline, 24/7 Wall St. projects huge upside for Novo Nordisk stock through 2030 ...

She admitted she turned to the controversial jab after gaining two stone in weight following the death of her best friend Femi in 2024.

Ascendis Pharma's TransCon platform shows promise, but challenges with rollout, competition, and execution risks lead to a Hold rating.

Serena Williams has joined telehealth company Ro as a celebrity ambassador for their weight-loss treatments. Williams will star in ads for GLP-1 medications and share her health journey post-pregnancy ...

The United States and European Union on Thursday released new details of their trade framework, providing clarity on tariffs for sectors including pharmaceuticals, semiconductors, and autos after ...